Gamida Cell Ltd.
GMDA · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $2 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $3 | $0 | $0 | $0 |
| Gross Profit | -$2 | -$0 | -$0 | -$0 |
| % Margin | -95% | – | – | – |
| R&D Expenses | $22 | $43 | $50 | $41 |
| G&A Expenses | $45 | $19 | $17 | $12 |
| SG&A Expenses | $49 | $19 | $17 | $12 |
| Sales & Mktg Exp. | $4 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $13 | $20 | $9 |
| Operating Expenses | $71 | $75 | $87 | $62 |
| Operating Income | -$73 | $75 | -$87 | -$62 |
| % Margin | -4,094.1% | – | – | – |
| Other Income/Exp. Net | $10 | -$4 | -$3 | -$1 |
| Pre-Tax Income | -$63 | -$79 | -$90 | -$73 |
| Tax Expense | $0 | $0 | $0 | $4 |
| Net Income | -$63 | -$154 | -$92 | -$76 |
| % Margin | -3,531.2% | – | – | – |
| EPS | -0.42 | -2.42 | -1.56 | -1.75 |
| % Growth | 82.6% | -55.1% | 10.9% | – |
| EPS Diluted | -0.57 | -2.42 | -1.56 | -1.75 |
| Weighted Avg Shares Out | 149 | 64 | 59 | 44 |
| Weighted Avg Shares Out Dil | 149 | 64 | 59 | 44 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $0 | $0 | $0 |
| Interest Expense | $8 | $4 | $3 | $11 |
| Depreciation & Amortization | $2 | -$150 | $0 | $3 |
| EBITDA | -$53 | -$75 | -$87 | -$61 |
| % Margin | -2,992.4% | – | – | – |